BAM
BNTX icon

Byrne Asset Management’s BioNTech BNTX Stock Holding History

Byrne Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-21
Closed -$3K – 525
2022
Q3 		$3K Sell
21
-27
-56% -$4.13K ﹤0.01% 440
2022
Q2 		$7K Buy
48
+8
+20% +$1.22K 0.01% 389
2022
Q1 		$7K Buy
40
+19
+90% +$3.19K ﹤0.01% 415
2021
Q4 		$5K Buy
+21
New +$5.75K ﹤0.01% 453

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Byrne Asset Management's BNTX Position: Q4 2022 in Review

Byrne Asset Management sold out of BioNTech (BNTX) in Q4 2022, closing a stake of 21 shares — an estimated $3K sold.

Byrne Asset Management first reported a position in BNTX in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q2 2022. 320 funds tracked by Wall St. Rank hold BNTX as of Q4 2022.

  • Byrne Asset Management reported no remaining BioNTech position as of Q4 2022 after selling out during the quarter.
  • Byrne Asset Management sold 21 BioNTech shares in Q4 2022, an estimated $3K.
  • Byrne Asset Management first reported a position in BioNTech in Q4 2021 and held it in 4 quarters.
  • Byrne Asset Management's BioNTech position peaked at $7K in Q2 2022.
  • 320 funds tracked by Wall St. Rank held BioNTech as of Q4 2022.

Based on Byrne Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.